ArticleFrontiers in oncology2026
Self-identified African ancestry and pathomics-derived tumor-infiltrating lymphocyte scores in colon and rectal adenocarcinoma whole-slide images: an exploratory multicohort whole-slide image study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Introduction: AI assisted computed higher tumor infiltrating lymphocyte% (TIL%) scores from hematoxylin and eosin (H&E) stained whole slide images (WSI) may serve as a useful biomarker for stratifying patients for treatment with immune checkpoint inhibitors. Methods: To test the hypothesis that self-identified African ancestry (AA) vs. European ancestry (EA) was associated with higher TIL% scores, WSI were assembled from three diverse cohorts of formalin-fixed paraffin embedded (FFPE) colon and rectal adenocarcinoma (COAD-READ) tumor tissues: 1.) 242 AA vs. EA WSI downloaded from The Cancer Genome Atlas (TCGA)-COAD-READ database; 2.) 97 independent US self-identified AA vs. EA WSI assembled from three US medical centers; 3.) 48 (of 51) Nigerian WSI assembled from a single Nigerian medical center. There were 33 self-identified AA WSI suitable for analysis in the TCGA cohort and 49 self-identified AA WSI in the US cohort. For the TCGA cohort, 241 whole transcriptome RNA-sequence data were generated from parallel frozen tumor samples collected alongside the FFPE samples. For the US cohort, 87 RNA-seq enriched by exome capture data were generated from the same FFPE blocks as WSI. Results: No difference in median TIL% scores was detected between the combined TCGA and US AA cohorts and the Nigerian cohort. Exploratory multiple regression analysis of the combined TCGA and US cohorts revealed that AA had a higher TIL% score (Estimated difference = 3.01%, 95% CI (0.54%, 5.49%), P-value = 0.0170), while controlling for MMR/MSI status and other covariates. However, this result needs to be interpreted with caution because of differences between the TCGA and US cohorts with respect to representation of self-identified AA. After adjustment for cohort in the model, the association of AA with a higher TIL% score was no longer significant (Estimated difference = 2.05%, 95% CI(-0.59%, 4.70%), P-value = 0.1277). Moderate correlations were detected in the TCGA and US cohorts analyzed separately between computed TIL% scores and CIBERSORTx estimates of lymphocyte and T-cell abundance. Moderate correlations were also detected between TIL% scores and CXCL10 and CCL5 gene expression values. Conclusions: These preliminary results underscore the need for expanding the representation of minority populations in publicly accessible datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.